• AJMCAJMC
  • Center for Biosimilars
Center for Biosimilars®
Center for Biosimilars®
Business Practice
View MoreBusinessDevelopmentLegalPolicyPracticeRegulatory
News
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Compendia
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Polls
WHEN CHOICE ARRIVES: Competition & Consequences
SubscribeBIOSIMILAR APPROVALS
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2023 MJH Life Sciences and Center for Biosimilars®. All rights reserved.

Advertisement
Business PracticeSee All >
  • Business
  • Development
  • Legal
  • Policy
  • Practice
  • Regulatory
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.

American Conference Institute: Summit on Biosimilars & Innovator Biologics

  1. home

ACI Panelists Discuss Misaligned Incentives in the Biosimilars Market

July 15th 2021

Article

Panelists at the American Conference Institute's 2021 meeting took on the complexities of biosimilar adoption in a wide-ranging discussion.

Amgen Executive Weighs the Challenges for Interchangeable Biosimilars

June 25th 2021

Article

A turning point for interchangeable biosimilars has arrived, as the first may be approved this year, but many questions about these agents have yet to be answered, according to Laura Sim, senior counsel for Amgen.

Pharmaceutical Pay-for-Delay Settlements "Have a Good Side"

June 23rd 2021

Article

Pay-for-delay settlements between drug companies are better regulated than in the past and are in danger of being overregulated, one panelist said.

Advertisement
Advertisement